NONCLINICAL TOXICOLOGY Carcinogenesis, Mutagenesis, Impairment of Fertility In a 2-year carcinogenicity study in CD-1 mice, subcutaneous doses of 0.3, 1 and 3 mg/kg/day [2-, 11-, and 30-fold the maximum recommended human dose (MRHD) of 2 mg/week, based on AUC] were administered to the males, and 0.1, 0.3 and 1 mg/kg/day (1-, 2-, and 7-fold MRHD) were administered to the females
This is due to the digestive process, which can break down a portion of the vitamin before it reaches your bloodstream
TfR mediates the delivery of iron to the bloodbrain barrier and intracellular trafficking of the iron-binding protein transferrin
Its clinician-developed and monitored and designed to work alongside other midlife treatments, including hormone therapy, when appropriate